Drug Trial Radar · NCT06757010
A Study of NE3107 in Early Parkinson's
Last checked: Nov 19, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
57
Actual
Start
Mar 26, 2025
Primary completion
May 1, 2026
Study completion May 31, 2026
Sponsor
- Lead sponsor
- BioVie Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if bezisterim can treat movement symptoms of Parkinson's disease in patients that are 45 to 80 years old, in generally good physical and mental health, and are nearing the need for treatment to relieve their symptoms but have not yet been prescribed any form of levodopa or drug with similar activity. The main questions it aims to answer are: * Will bezisterim decrease movement symptoms of Parkinson's disease? * What medical problems do participants have when taking bezisterim? Researchers will compare the effects of bezisterim treatment to placebo (a look-alike substance that contains no drug) to see if bezisterim works to treat movement symptoms of Parkinson's disease. Participants will * have a physical examination that includes an electrocardiogram * take drug or placebo twice daily for four months * visit a clinical site or receive an at home visit seven times over the course of five months
Conditions
- Parkinsons Disease (PD)
Interventions
NE3107Drug
NE3107 20 mg BID
PlaceboDrug
Placebo BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Monocyte Lymphocyte Ratio (MLR)Time frame: 12 Weeks
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Quest Research Institute
Farmington Hills, Michigan
Dent Neurologic
Amherst, New York
Science 37 (Nationwide Site)
Morrisville, North Carolina
NeuroScience Research Center, LLC
Canton, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.